Unlock instant, AI-driven research and patent intelligence for your innovation.

ELISA detection of urine DEK to predict and diagnose bladder cancer in humans

a technology of urine dek and human bladder, which is applied in the field of urine dek detection method to predict and diagnose bladder cancer in humans, can solve the problems of poor patient compliance, invasiveness, and high cost, and achieve the effect of avoiding false positives, avoiding false positives, and avoiding false positives

Active Publication Date: 2016-02-09
MEDICAL DIAGNOSTIC LAB
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method for detecting DEK in a urine sample of a human, which is an indicator of bladder cancer. The method involves concentrating the urine sample and inducing the formation of a precipitate using a chemical compound. The precipitate is then re-suspended in a polar solvent and the solution has a final volume that is 10-50 fold less than the original urine sample. The solution is then filtered and the presence of DEK is detected using an anti-DEK antibody in a Western blot assay. The invention also provides a kit for detecting DEK in a urine sample. The technical effect of the invention is to provide a reliable and sensitive method for detecting bladder cancer in humans.

Problems solved by technology

It is invasive, unpleasant, and expensive, which in turn leads to poor patient compliance.
In addition, cystoscopy often yields false-positive results.
However, none have acceptable sensitivity and specificity as a routine tool for bladder cancer diagnostics and surveillance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
  • ELISA detection of urine DEK to predict and diagnose bladder cancer in humans

Examples

Experimental program
Comparison scheme
Effect test

example 1

Western Blot Detection of DEK Protein in Bladder Cell Lines

[0176]In this series of studies, we optimized the detection of DEK protein in a biological sample (e.g., urine) using Western blot assay. We tested cell lysate extracts obtained from four (4) bladder cancer cell lines (i.e., RT-4, 5637, T-24 and TCCSUP) and examined their DEK protein expression. These cells were chosen to represent different stages of bladder cancer. In addition, we tested cell extracts from bladder epithelial cells transformed with SV-40 T-antigen (i.e., UroTSA), progenitor human epithelial cells (i.e., HBEP cells), and differentiated HBEP cells for their DEK protein expression. Note that HBEP cells were treated with 1 mM calcium chloride to prevent cycling in growth media.

[0177]Cell extracts from 1×107 cells were obtained using RIPA buffer (i.e., 25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS). Protein was quantified using a BCA assay kit (Pierce, Thermo Fisher Scienti...

example 2

Western Blot Fails to Detect DEK Protein in Cultured Media

[0180]In this study, we examined if DEK protein can be released from bladder cancer cells (i.e., secreted from cells). To do so, we first collected cultured media from two (2) bladder cancer cell lines (i.e., T-24 and 5637) and then examined DEK protein expression in these cultured media. One (1) ml of cultured media was collected and briefly centrifuged (3,000 rpm, 5 min) to remove any cellular debris. The cultured media was subsequently concentrated to 50-fold (i.e., from 500 μl to 10 μl) using a Microcon® 3K filter (Millipore, Billerica, Mass.). The entire 10 μl of the concentrated cultured media sample was loaded in a Western blot assay. DEK protein was examined using a polyclonal anti-DEK antibody (cat. no. A-301-335A) (Bethyl Labs., Montgomery, Tex.). UroTSA (10 μg) whole cell lysate was used as a control.

[0181]FIG. 2 shows that DEK protein was not detectable in the cultured media of the two (2) bladder cancer cell line...

example 3

Western Blot Detection of DEK Protein in Bladder Tissues

[0182]In this study, we examined if our Western blot assay (see Example 1) could detect DEK protein in bladder tissues obtained from human subjects (e.g., bladder cancer patients or healthy individuals).

[0183]Twenty-seven (27) bladder tumor tissue samples were obtained from patients who suffered from low and high grade transitional cell carcinoma (TCC). For comparison, twenty-seven (27) normal bladder tissue samples were obtained from the adjacent sites of the same individuals. Tissue lysate extracts were prepared using RIPA buffer (as described above) and the tissue extracts were prepared to a protein concentration of 2-10 μg / μL. Protein concentration of the tissue lysates extracts was determined using a BCA assay kit (Pierce, Thermo Fisher Scientific, Rockford, Ill.). ˜50 μg of the tissue lysates extracts from each sample was analyzed for their DEK protein expression in our Western blot assay, using a monoclonal anti-DEK anti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationsaaaaaaaaaa
concentrationsaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. Methods and compositions for detection of DEK using mAb 260-6F9F6 (as detection antibody) and mAb 16-2C9C3 (as capture antibody) in human urine are provided herein. Specifically, the ELISA assay utilizes a capture mAb and a detection mAb to yield a high sensitivity of <50 ng / mL. The presence of DEK in urine is useful in predicting or diagnosing the occurrence of bladder cancer in humans.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a continuation-in-part (CIP) of the utility application Ser. No. 13 / 317,531 filed Oct. 20, 2011, (now U.S Pat. No. 8,741,582),which claims the benefit of priority under 35 U.S.C. §119(e) to U.S. Provisional Application Nos. 61 / 455,406 filed Oct. 20, 2010 and 61 / 455,405 filed Oct. 20, 2010, the disclosures of which are hereby incorporated by reference in their entireties.FIELD OF INVENTION[0002]The present invention generally relates to a method of detecting a DEK protein in a urine sample. Specifically, the present invention relates to a method of detecting and diagnosing bladder cancer in humans by ELISA to detect DEK in human urine. The ELISA utilizes a first monoclonal antibody to capture DEK and a second monoclonal antibody to detect DEK to provide a high sensitivity assay (i.e., limit of detection <50 ng / mL). The present ELISA method permits a quantitative correlation between the presence of a DEK protei...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): G01N33/574C07K16/18
CPCG01N33/57407C07K16/18G01N33/574G01N2333/82
Inventor DATTA, ANTARATRAMA, JASON
Owner MEDICAL DIAGNOSTIC LAB